The German Football League (DFL) has become a new shareholder in the streaming service Dyn, a media company owned by former DFL managing director Christian Seifert. The completion of the transaction ...

Dyne Therapeutics, Inc. (NASDAQ:DYN) is among the 14 best booming stocks to buy right now, with returns of over 23% in the ...

Dyne Therapeutics, Inc. develops treatments for muscle diseases using its FORCE platform, with promising candidates DYNE-101 and DYNE-251 targeting DM1 and DMD, respectively. DYNE-251 shows ...

In a report released today, Edward Tenthoff from Piper Sandler reiterated a Buy rating on Dyne Therapeutics (DYN – Research Report), with a price target of $53.00. The company’s shares closed ...

Dyne Therapeutics (NASDAQ:DYN) is one of the most promising mid-cap healthcare stocks under $50. As of the December 19 closing, the consensus analyst sentiment towards Dyne Therapeutics (NASDAQ:DYN) ...

Piper Sandler analyst Edward Tenthoff reiterated a Buy rating on Dyne Therapeutics (DYN – Research Report) today and set a price target of $53.00. The company’s shares closed last Friday at $25.73.

Dyn Inc. is on a buying spree. The Manchester, N.H.-based Internet Infrastructure as a Service provider has bought mobile dashboard app startup Trendslide, a New Hampshire startup that was backed by ...